| Typicality: | 0.588 |
| Saliency: | 0.412 |
| for 30 days | 9 | temporal |
| in one study | 6 | location |
| to receive standard curcumin | 6 | purpose |
| subject → be randomized to → placebo | 39 |
| subject → be randomized to receive → placebo | 13 |
| subject → be randomised to receive → placebo | 7 |
| subject → randomize to → placebo | 6 |
| subject → be randomized into → placebo groups | 3 |
| subject → be randomised to → placebo | 3 |
| negative | neutral | positive |
| 0.116 | 0.830 | 0.054 |
| Raw frequency | 71 |
| Normalized frequency | 0.412 |
| Modifier score | 1.000 |
| Perplexity | 56.922 |